Topic resource collection
Approved comparison material connected to this topic.
56 resourcesRead both sides
Thymosin Alpha-1 Restores regulatory T-cell differentiation, reduces TGF-beta-1-driven inflammation 8–12 weeks Does not clear mycotoxins; requires environmental remediation first First-line immune modulator for CIRS. Addresses ro…
DSIP Delta-opioid receptor agonist. Reduces cortisol-driven wakefulness 60–90 minutes before sleep 100–500 mcg subcutaneous Sleep-onset insomnia, stress-related waking Works fastest but requires consistent timing. Miss the window…
DSIP analogs −20°C lyophilised, 2–8°C reconstituted 60–90 min before sleep GABAergic modulation at hypothalamus 60–90 minutes Best for sleep onset; requires precise timing Thymalin 90 min before sleep Thymus-hypothalamus axis, ci…
Dihexa HGF receptor agonist → BDNF upregulation 1–5mg/mL Daily Morning (6–10 AM) Best for learning and memory consolidation tasks; 7× more potent than BDNF in synaptogenesis studies Cerebrolysin NGF-mimetic neuropeptide blend Pre…
CJC-1295 + Ipamorelin GHRH analog + ghrelin mimetic. Amplifies GH pulse amplitude and duration 200–300mcg each per injection 3–5 times weekly, pre-training or bedtime Moderate (Phase 2 trials, peer-reviewed observational data) St…
| Protocol Element | PT-141 (Bremelanotide) | Sildenafil (Viagra) | Professional Assessment ||—|—|—|| Mechanism of Action | Melanocortin receptor (MC3R/MC4R) agonist in CNS. Activates hypothalamic arousal pathways | PDE5 inhibito…
Primary Receptor Target Melanocortin-4 receptor (MC4R) in hypothalamus KISS1R on GnRH neurons in arcuate nucleus PT-141 acts directly on CNS desire pathways; kisspeptin modulates upstream hormonal regulation Mechanism of Action A…
BPC-157 Upregulates growth hormone receptors in fibroblasts; accelerates collagen synthesis in ligaments and annular tears 250–500 mcg/day subcutaneous, near injury site, 4–8 weeks Rodent models show 72% increase in tendon tensil…
Before selecting a secretagogue, understand the trade-offs between receptor specificity, half-life, and secondary hormonal effects. CJC-1295 (no DAC) GHRH analog. Direct pituitary stimulation 30 minutes 100–200mcg 2–3×/day Minima…
Thymalin Thymulin receptor agonist. Promotes T-cell maturation in thymic tissue Thymic epithelial cells, T-lymphocyte progenitors 5–10mg per injection 2–3 times weekly Phase 2 trials showing 34% naive T-cell increase over 8 weeks…
GHK-Cu (Copper Peptide) DHT receptor blockade + TGF-β upregulation Androgenetic alopecia (pattern baldness) Topical post-microneedling 2–3× weekly, 1% concentration Gold standard for miniaturised follicle reversal. Best evidence …
Before selecting peptides for detoxification research, compare their mechanisms, bioavailability, and documented outcomes. Not all peptides target the same detox pathways—some enhance antioxidant enzyme transcription, others supp…
Before selecting a peptide for ulcer healing, compare the mechanisms, dosing standards, and evidence base for the most-researched compounds. BPC-157 Stimulates VEGF and fibroblast growth factor; promotes angiogenesis in damaged m…
Before selecting a peptide for memory research, understanding the comparative profiles across mechanism, dosing, timeline, and application context is essential. The table below distills clinical and preclinical evidence for the m…
BPC-157 Upregulates VEGF and FGF to increase capillary density; modulates TGF-β1 to reduce inflammatory cytokines Daily (250–500 mcg) Localized. Within 2–3 cm of plantar fascia Accelerates collagen synthesis and tensile strength …
MC1R Selectivity High (13x selective for MC1R) Low (non-selective across MC1R, MC3R, MC4R, MC5R) MT-I produces pigmentation with fewer systemic side effects but requires higher cumulative dose Pigmentation Speed Moderate (2–3 wee…
CJC-1295 / Ipamorelin GHRH + ghrelin mimetic. Stimulates GH release, which upregulates LH and testosterone synthesis CJC: 500 mcg 2×/week; Ipamorelin: 200–300 mcg daily before bed 6–10 weeks for measurable testosterone increase Y…
BPC-157 Promotes angiogenesis, upregulates VEGF and bFGF, accelerates mucosal healing 250–500mcg daily Once daily ~4 hours (requires daily dosing) Most evidence for direct GI tissue repair; studied extensively in colitis models T…
Before selecting a peptide, understand how each compound differs in mechanism, target tissue, administration route, and evidence base. BPC-157 VEGF upregulation, angiogenesis, nitric oxide stabilization Mucosal injury, IBD, NSAID…
Mechanism Upregulates VEGF and growth hormone receptors; enhances fibroblast migration to injury site Promotes actin polymerisation and angiogenesis; reduces inflammation via downregulation of pro-inflammatory cytokines Complemen…